How many drugs treat Allergic Rhinitis Prevention?

Drug Landscape tracks 4 marketed treatments for Allergic Rhinitis Prevention (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/allergic-rhinitis-prevention.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Allergic Rhinitis Prevention — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Allergic Rhinitis Prevention (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Allergic Rhinitis Prevention, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Pulmicort Respules	BUDESONIDE	AstraZeneca K.K.	Corticosteroid [EPC]	Glucocorticoid receptor	1994-01-01
Elocon	MOMETASONE FUROATE	Merck & Co.	Corticosteroid	Progesterone receptor	1987-01-01
Verdeso	DESONIDE	Padagis Us	Corticosteroid [EPC]	Glucocorticoid receptor	1972-01-01
Nasonex	Nasonex	University of Alberta		Multidrug resistance protein 1, Glucocorticoid receptor, Progesterone receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 3 drugs in Allergic Rhinitis Prevention
AstraZeneca K.K. · 1 drug in Allergic Rhinitis Prevention
Merck & Co. · 1 drug in Allergic Rhinitis Prevention
Padagis Us · 1 drug in Allergic Rhinitis Prevention
University of Alberta · 1 drug in Allergic Rhinitis Prevention

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Allergic Rhinitis Prevention:

Cite this brief

Drug Landscape (2026). Allergic Rhinitis Prevention — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/allergic-rhinitis-prevention. Accessed 2026-06-10.

Allergic Rhinitis Prevention full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing